These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31482731)

  • 1. Involvement of high mobility group box 1 in the pathogenesis of severe hemolytic uremic syndrome in a murine model.
    Maeda R; Kawasaki Y; Kume Y; Go H; Suyama K; Hosoya M
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1420-F1429. PubMed ID: 31482731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice.
    Suyama K; Kawasaki Y; Miyazaki K; Kanno S; Ono A; Ohara S; Sato M; Hosoya M
    Nephrol Dial Transplant; 2015 Jun; 30(6):969-77. PubMed ID: 25694534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease.
    Keepers TR; Psotka MA; Gross LK; Obrig TG
    J Am Soc Nephrol; 2006 Dec; 17(12):3404-14. PubMed ID: 17082244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protective effect of neutralizing high-mobility group box1 against chronic cyclosporine nephrotoxicity in mice.
    Park HS; Kim EN; Kim MY; Lim JH; Kim HW; Park CW; Yang CW; Jin DC; Choi BS
    Transpl Immunol; 2016 Feb; 34():42-9. PubMed ID: 26603313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome.
    Ohara S; Kawasaki Y; Abe Y; Watanabe M; Ono A; Suyama K; Hashimoto K; Honda T; Suzuki J; Hosoya M
    Am J Nephrol; 2012; 36(6):516-23. PubMed ID: 23171542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model for hemolytic uremic syndrome induced by outer membrane vesicles of Escherichia coli O157:H7.
    Kim SH; Lee YH; Lee SH; Lee SR; Huh JW; Kim SU; Chang KT
    FEMS Immunol Med Microbiol; 2011 Dec; 63(3):427-34. PubMed ID: 22029600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of interleukin-10 reduces progression of shiga toxin-induced hemolytic uremic syndrome.
    Pineda GE; Rearte B; Todero MF; Bruballa AC; Bernal AM; Fernandez-Brando RJ; Isturiz MA; Zotta E; Alba-Soto CD; Palermo MS; Ramos MV
    Clin Sci (Lond); 2021 Feb; 135(3):575-588. PubMed ID: 33496327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mobility group box 1 mediates persistent splenocyte priming in sepsis survivors: evidence from a murine model.
    Valdés-Ferrer SI; Rosas-Ballina M; Olofsson PS; Lu B; Dancho ME; Li J; Yang H; Pavlov VA; Chavan SS; Tracey KJ
    Shock; 2013 Dec; 40(6):492-5. PubMed ID: 24089009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.
    Ikeda M; Ito S; Honda M
    Pediatr Nephrol; 2004 May; 19(5):485-9. PubMed ID: 15007712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile and injury sites in mice treated with Shiga toxin 2 and lipopolysaccharide as a Shiga toxin-associated hemolytic uremic syndrome model.
    Kume Y; Go H; Maeda R; Suyama K; Mori T; Kawasaki Y; Hashimoto K; Hosoya M
    Physiol Genomics; 2022 May; 54(5):153-165. PubMed ID: 35384732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penehyclidine hydrochloride inhibits the release of high-mobility group box 1 in lipopolysaccharide-activated RAW264.7 cells and cecal ligation and puncture-induced septic mice.
    Yang Q; Liu X; Yao Z; Mao S; Wei Q; Chang Y
    J Surg Res; 2014 Jan; 186(1):310-7. PubMed ID: 24124976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.
    Shimazaki J; Matsumoto N; Ogura H; Muroya T; Kuwagata Y; Nakagawa J; Yamakawa K; Hosotsubo H; Imamura Y; Shimazu T
    Shock; 2012 Jun; 37(6):634-8. PubMed ID: 22392147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet-induced obesity precipitates kidney dysfunction and alters inflammatory mediators in mice treated with Shiga Toxin 2.
    Harrison LM; Gaines DW; Babu US; Balan KV; Reimschuessel R; Do AB; Pereira MR; Bigley EC; Ferguson M; Mehta A; Williams KM
    Microb Pathog; 2018 Oct; 123():250-258. PubMed ID: 30016681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
    Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
    J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products (AGEs) synergistically potentiated the proinflammatory action of lipopolysaccharide (LPS) and high mobility group box-1 (HMGB1) through their direct interactions.
    Watanabe M; Toyomura T; Tomiyama M; Wake H; Liu K; Teshigawara K; Takahashi H; Nishibori M; Mori S
    Mol Biol Rep; 2020 Sep; 47(9):7153-7159. PubMed ID: 32885364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Mobility Group Box1 Inhibitor Glycyrrhizic Acid Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats.
    Zhang H; Zhang R; Chen J; Shi M; Li W; Zhang X
    Kidney Blood Press Res; 2017; 42(5):894-904. PubMed ID: 29241180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.
    Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q
    PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury.
    Qing X; Pitashny M; Thomas DB; Barrat FJ; Hogarth MP; Putterman C
    Immunol Lett; 2008 Nov; 121(1):61-73. PubMed ID: 18822317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
    Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
    Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.